A First-in-Patient Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease
Clinical trial NCT07377565 · RECRUITING
Trial details
- NCT number
- NCT07377565
- Sponsor
- Nielsen Fernandez-Becker
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-29
- Primary completion
- 2027-06-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.